FDA warns of CARDIAC INFLAMMATION risk linked to the Novavax COVID-19 vaccine

Food and Drug Administration (FDA) staffers warned of the potential cardiac inflammation risk linked to the Wuhan coronavirus (COVID-19) vaccine from Novavax. The regulatory agency’s staff members pointed out the risk in documents released June 3, ahead of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting scheduled on June 7. They cited four events of myocarditis – … Continue reading FDA warns of CARDIAC INFLAMMATION risk linked to the Novavax COVID-19 vaccine